Biobeat Reports Interim Data for Chest Patch
The clinical trial evaluates a single-use, chest-worn device that monitors heart rate and blood pressure.
Updated on Oct. 28, 2026 in Heart Disease
Live Poll
Would you trust a wearable chest patch over a traditional blood pressure cuff for medical diagnosis?
Biobeat has released interim results from a 600-patient clinical trial for its FDA-cleared, chest-worn monitoring patch. The device is designed to track vital signs over a 24-hour period.
Why it matters
The performance of new wearable technology is critical as regulators and medical associations continue to evaluate the clinical utility of remote monitoring devices for chronic conditions.
The clinical trial utilizes a sample size of 600 patients to assess the performance of the chest-worn monitor. The device is engineered to provide continuous vital sign tracking over a 24-hour duration.
The players
Biobeat
Biobeat is a medical technology company that develops wearable devices for remote patient monitoring.
FDA
The Food and Drug Administration is the United States federal agency responsible for regulating medical devices and ensuring their safety and efficacy.
The details
The Biobeat patch functions as a single-use wearable that monitors both heart rate and blood pressure. It currently holds FDA clearance for use within the United States.
Timeline
2025: AHA/ACC hypertension guideline published.
Health Landscape
The development follows the publication of the 2025 AHA/ACC hypertension guideline, which currently advises against the use of cuffless devices for diagnostic purposes. This regulatory posture defines the challenging environment for manufacturers of wearable blood pressure monitoring technology.
Patients may see new wearable options for monitoring their vital signs as these devices undergo further testing. However, users should consult their doctors regarding the clinical validity of these patches for diagnostic purposes according to current medical guidelines.
The takeaway
The medical community is closely watching how wearable technology aligns with established clinical diagnostic standards. Patients should ensure they understand whether a wearable is intended for general health tracking or medical diagnosis before making personal health decisions.
Further reading
Learn more about the latest research and diagnostic tools in our Heart Disease section.
Source note: This article includes information reported by Insights.
Live Poll
Would you trust a wearable chest patch over a traditional blood pressure cuff for medical diagnosis?
